The story of Sildenafil presents a challenging picture for shareholders. While the initial launch generated substantial profits, the expiration of its intellectual property protection opened the door to generic https://prestontows872091.blogsidea.com/48631189/the-copyright-and-pharma-a-risky-opportunity